1. Home
  2. MNMD vs TWI Comparison

MNMD vs TWI Comparison

Compare MNMD & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • TWI
  • Stock Information
  • Founded
  • MNMD 2019
  • TWI 1890
  • Country
  • MNMD United States
  • TWI United States
  • Employees
  • MNMD N/A
  • TWI N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • TWI Steel/Iron Ore
  • Sector
  • MNMD Health Care
  • TWI Industrials
  • Exchange
  • MNMD Nasdaq
  • TWI Nasdaq
  • Market Cap
  • MNMD 509.2M
  • TWI 535.4M
  • IPO Year
  • MNMD N/A
  • TWI 1993
  • Fundamental
  • Price
  • MNMD $9.22
  • TWI $8.80
  • Analyst Decision
  • MNMD Strong Buy
  • TWI Strong Buy
  • Analyst Count
  • MNMD 7
  • TWI 2
  • Target Price
  • MNMD $24.71
  • TWI $11.50
  • AVG Volume (30 Days)
  • MNMD 1.2M
  • TWI 378.1K
  • Earning Date
  • MNMD 11-06-2025
  • TWI 10-29-2025
  • Dividend Yield
  • MNMD N/A
  • TWI N/A
  • EPS Growth
  • MNMD N/A
  • TWI N/A
  • EPS
  • MNMD N/A
  • TWI N/A
  • Revenue
  • MNMD N/A
  • TWI $1,783,096,000.00
  • Revenue This Year
  • MNMD N/A
  • TWI $0.87
  • Revenue Next Year
  • MNMD N/A
  • TWI $5.21
  • P/E Ratio
  • MNMD N/A
  • TWI N/A
  • Revenue Growth
  • MNMD N/A
  • TWI N/A
  • 52 Week Low
  • MNMD $4.70
  • TWI $5.93
  • 52 Week High
  • MNMD $11.02
  • TWI $10.94
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 47.40
  • TWI 48.82
  • Support Level
  • MNMD $8.70
  • TWI $8.53
  • Resistance Level
  • MNMD $9.30
  • TWI $8.84
  • Average True Range (ATR)
  • MNMD 0.58
  • TWI 0.29
  • MACD
  • MNMD -0.13
  • TWI 0.02
  • Stochastic Oscillator
  • MNMD 22.41
  • TWI 46.67

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: